ALPHA (psychedelic)
Jump to navigation
Jump to search
This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these template messages)
|
Clinical data | |
---|---|
Routes of administration | Oral |
ATC code |
|
Pharmacokinetic data | |
Metabolism | Hepatic |
Excretion | Renal |
Identifiers | |
| |
CAS Number | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C10H13NO2 |
Molar mass | 179.219 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
ALPHA (alpha-ethyl-3,4-methylenedioxybenzylamine) is a lesser-known psychedelic drug and a substituted benzylamine. It is also the benzylamine analog of 3,4-methylenedioxyamphetamine (MDA). ALPHA was first synthesized by Alexander Shulgin. In his book PIHKAL on the MDA page, the threshold dosage is listed as 10 mg.[1] At mild threshold dosages (around 10 mg) there are eyes-closed "dreams" with some body tingling, at higher doses (up to 140 mg) was reported to produce a pleasant, positive feeling. This compound is not anoretic at any dose. It lasts about 3 hours. Very little data exists about the pharmacological properties, metabolism, and toxicity of ALPHA.
See also
- M-ALPHA (N-methyl analogue)
- Indanorex
- Phenethylamine
- Psychedelics, dissociatives and deliriants
References
Categories:
- Articles with short description
- Short description matches Wikidata
- Articles with topics of unclear notability from October 2017
- All articles with topics of unclear notability
- Articles needing additional references from October 2017
- All articles needing additional references
- Articles with multiple maintenance issues
- Drugs not assigned an ATC code
- Infobox drug articles with non-default infobox title
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Drugs with no legal status
- Psychedelic drugs
- All stub articles
- Psychoactive drug stubs